Airain Ltd’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$444K Sell
3,930
-19,724
-83% -$2.2M 0.02% 566
2017
Q1
$2.37M Buy
23,654
+16,932
+252% +$1.81M 0.12% 205
2016
Q4
$723K Sell
6,722
-15,385
-70% -$1.8M 0.06% 297
2016
Q3
$2.75M Buy
+22,107
New +$2.61M 0.16% 183
2015
Q4
Sell
-15,756
Closed -$1.42M 1184
2015
Q3
$1.42M Buy
15,756
+5,619
+55% +$593K 0.08% 283
2015
Q2
$1.17M Buy
+10,137
New +$1.07M 0.07% 311

Other funds holding CBPO

Airain Ltd's CBPO Position: Q2 2017 in Review

Airain Ltd reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 83% in Q2 2017, selling an estimated $2.2M and leaving 3,930 shares worth $444K. The position accounts for 0.02% of the portfolio, ranked #566.

Airain Ltd first reported a position in CBPO in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.75M in Q3 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

  • Airain Ltd held 3,930 shares of China Biologic Products Holdings, Inc. worth $444K as of Q2 2017.
  • Airain Ltd sold 19,724 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $2.2M.
  • China Biologic Products Holdings, Inc. made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #566 holding.
  • Airain Ltd first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and has held it in 6 quarters since.
  • Airain Ltd's China Biologic Products Holdings, Inc. position peaked at $2.75M in Q3 2016.
  • 119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.